Antibiotic resistance of bacterial biofilms
2010/02/11 by Niels Høiby, Thomas Bjarnsholt, Michael Givskov +2 · 40 citations
Biochemistry, Genetics and Molecular Biology · Dentistry · #Bacterial biofilms and quorum sensing #Oral microbiology and periodontitis research #Antibiotic Resistance in Bacteria
paper · doi:10.1016/j.ijantimicag.2009.12.011
Abstract
A biofilm is a structured consortium of bacteria embedded in a self-produced polymer matrix consisting of polysaccharide, protein and DNA. Bacterial biofilms cause chronic infections because they show increased tolerance to antibiotics and disinfectant chemicals as well as resisting phagocytosis and other components of the body's defence system. The persistence of, for example, staphylococcal infections related to foreign bodies is due to biofilm formation. Likewise, chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is caused by biofilm-growing mucoid strains. Characteristically, gradients of nutrients and oxygen exist from the top to the bottom of biofilms and these gradients are associated with decreased bacterial metabolic activity and increased doubling times of the bacterial cells; it is these more or less dormant cells that are responsible for some of the tolerance to antibiotics. Biofilm growth is associated with an increased level of mutations as well as with quorum-sensing-regulated mechanisms. Conventional resistance mechanisms such as chromosomal beta-lactamase, upregulated efflux pumps and mutations in antibiotic target molecules in bacteria also contribute to the survival of biofilms. Biofilms can be prevented by early aggressive antibiotic prophylaxis or therapy and they can be treated by chronic suppressive therapy. A promising strategy may be the use of enzymes that can dissolve the biofilm matrix (e.g. DNase and alginate lyase) as well as quorum-sensing inhibitors that increase biofilm susceptibility to antibiotics.
Cited by
- Surface Sensing and Adaptation in Bacteria
- Disruption of Pseudomonas aeruginosa quorum sensing influences biofilm formation without affecting antibiotic tolerance
- Pseudomonas aeruginosa gene expression changes during established biofilm infection in a cystic fibrosis lung model
- New insights into the inhibitory roles and mechanisms of D-amino acids in bacterial biofilms in medicine, industry, and agriculture
- Genomic insights and phenotypic characterization of three multidrug resistant Cupriavidus strains from the cystic fibrosis lung
- Mechanisms of antimicrobial resistance in biofilms
- Antibiofilm efficacy of a green graphene oxide-silver nanocomposite against mixed microbial species biofilms: an in vitro and in silico approach
- Plastics as vectors for pathogens and antibiotic resistance genes in aquatic systems
- A model, mixed-species urinary catheter biofilm derived from spinal cord injury patients
- Phage liquid crystalline droplets form occlusive sheaths that encapsulate and protect infectious rod-shaped bacteria
- Identifiability, Sensitivity, and Genetic Algorithms in Bacterial Biofilm Selection Models
- Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
- The multifaceted role of tannic acid: From its extraction and structure to antibacterial properties and applications
- Plasma-activated water: a powerful tool against pesky biofilms
- Antimicrobial Resistance in ESKAPE Pathogens
- Pseudomonas aeruginosa: resistance to the max. [europepmc]
- Horizontal gene exchange in environmental microbiota. [europepmc]
- Role of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilm. [europepmc]
- Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era. [europepmc]
- Microbial persistence and the road to drug resistance. [europepmc]
- Antibiotic alternatives: the substitution of antibiotics in animal husbandry? [europepmc]
- Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. [europepmc]
- Biofilms in periprosthetic orthopedic infections. [europepmc]
- Methicillin resistance and the biofilm phenotype in Staphylococcus aureus. [europepmc]
- Bacterial Extracellular Polysaccharides in Biofilm Formation and Function. [europepmc]
- The role of biofilms as environmental reservoirs of antibiotic resistance. [europepmc]
- Role of Multicellular Aggregates in Biofilm Formation. [europepmc]
- Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens. [europepmc]
- Antimicrobial Photodynamic Therapy to Control Clinically Relevant Biofilm Infections. [europepmc]
- Bacterial Metabolism and Antibiotic Efficacy. [europepmc]
- Periprosthetic joint infection: current concepts and outlook. [europepmc]
- Challenges of intervention, treatment, and antibiotic resistance of biofilm-forming microorganisms. [europepmc]
- Bacterial Biofilm Eradication Agents: A Current Review. [europepmc]
- Antimicrobial Resistance in ESKAPE Pathogens. [europepmc]
- Ecology and evolution of antimicrobial resistance in bacterial communities. [europepmc]
- The dental plaque biofilm matrix. [europepmc]
- Microbial biofilm: formation, architecture, antibiotic resistance, and control strategies. [europepmc]
- Multidrug Resistance (MDR): A Widespread Phenomenon in Pharmacological Therapies. [europepmc]
- Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades? [europepmc]
- Photothermal Nanomaterials: A Powerful Light-to-Heat Converter. [europepmc]
Related